ArriVent BioPharm signs license agreement with Laurus Labs for two MUTTA ADC molecules in India

ArriVent BioPharm announced a license agreement with Laurus Labs, under which Laurus Labs will obtain licenses for two MUTTA ADC molecules for development and commercialization in India.

Detected & updated continuously · Source: Nebula